DermTech Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:DermTech Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012886
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
DermTech Inc (DermTech) is a precision medicine developer that offers molecular tests. The company’s products include adhesive skin sample collection kit and pigmented lesion assay. Its EGIR platform technology is applicable in non-invasive, genomic-based disease detection, theranostics, pharmaceutical research and cosmeceutical development. DermTech’s tests find application in the areas of clinical research and dermatology, medical diagnostics and prognostics, pharmaceutical research and development, and theranostics and treatment decision-making. The company develops tests to assist the clinical diagnosis of skin cancers and other skin conditions. DermTech is headquartered in La Jolla, California, the US.

DermTech Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
DermTech Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
DermTech Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
DermTech Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
DermTech Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
DermTech Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
DermTech Inc, Medical Equipment, Deal Details 10
Venture Financing 10
DermTech Raises USD10 Million in Series C Financing 10
DermTech Raises Additional USD1 Million in Venture Financing 11
DermTech Raises USD2 Million in Venture Financing 12
DermTech Raises Additional USD2.55 Million in Venture Financing 13
DermTech Raises Additional USD1.8 Million in Venture Financing 14
DermTech Raises Additional USD0.77 Million in Financing Round 15
DermTech Raises USD0.58 Million in Venture Financing 16
DermTech Raises USD2.4 Million in Venture Financing 17
DermTech Raises US$5.6 Million In Initial Closing Of Series B Financing 18
Partnerships 19
DermTech Enters into Agreement with Dermpath Diagnostics 19
Equity Offering 20
DermTech Withdraws IPO 20
DermTech Inc – Key Competitors 21
DermTech Inc – Key Employees 22
DermTech Inc – Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Corporate Communications 24
Nov 07, 2017: DermTech Announces Addition of Harold Rabinovitz to Scientific Advisory Board 24
Sep 12, 2017: DermTech Appoints Gerald Krueger, MD, to Scientific Advisory Board 25
Aug 23, 2017: DermTech Announces Addition to Board of Directors 26
Jul 11, 2016: DermTech Announces Expansion of Board of Directors and Commercial Team 27
Legal and Regulatory 28
Apr 20, 2016: DermTech Receives CAP Accreditation 28
Product News 29
Apr 27, 2017: DermTech’s Utility Study Published in JAMA Dermatology 29
Mar 13, 2017: DermTech Presents Four Molecular Dermatology Studies at AAD 2017 30
03/08/2016: DermTech’s Late Breaking Abstract Presented at AAD 31
Other Significant Developments 32
Jan 09, 2017: DermTech Provides Business Update 32
May 02, 2016: DermTech Announces Preferred Provider Agreements with TriCare and ACPN and Credentialing by UnitedHealthcare 33
Mar 15, 2016: DermTech Enters Into Preferred Provider Agreements with Multiplan and FedMed 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
DermTech Inc, Medical Equipment, Key Facts 2
DermTech Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
DermTech Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
DermTech Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
DermTech Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
DermTech Inc, Deals By Market, 2011 to YTD 2017 8
DermTech Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
DermTech Raises USD10 Million in Series C Financing 10
DermTech Raises Additional USD1 Million in Venture Financing 11
DermTech Raises USD2 Million in Venture Financing 12
DermTech Raises Additional USD2.55 Million in Venture Financing 13
DermTech Raises Additional USD1.8 Million in Venture Financing 14
DermTech Raises Additional USD0.77 Million in Financing Round 15
DermTech Raises USD0.58 Million in Venture Financing 16
DermTech Raises USD2.4 Million in Venture Financing 17
DermTech Raises US$5.6 Million In Initial Closing Of Series B Financing 18
DermTech Enters into Agreement with Dermpath Diagnostics 19
DermTech Withdraws IPO 20
DermTech Inc, Key Competitors 21
DermTech Inc, Key Employees 22

★海外企業調査レポート[DermTech Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • University of Wollongong:企業の戦略的SWOT分析
    University of Wollongong - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Natus Medical Incorporated (BABY):医療機器:M&Aディール及び事業提携情報
    Summary Natus Medical Incorporated (Natus) is a provider of newborn and neurology healthcare products. It offers wide range of products for the screening, diagnosis, detection, treatment, monitoring and tracking of ailments in newborn. Natus offers products for diagnostic hearing assessment in child …
  • Imbed Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Imbed Biosciences Inc (Imbed) is a medical device company that develops technologies for imbedding bioactive molecules in wound dressings and surgical implants. The company’s polymeric microfilm product platform develops bioactive molecules on tissue surfaces to manage wound infections, biof …
  • Carnegie Private Bank:企業の戦略・SWOT・財務情報
    Carnegie Private Bank - Strategy, SWOT and Corporate Finance Report Summary Carnegie Private Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Orange and Rockland Utilities, Inc.:企業の戦略的SWOT分析
    Orange and Rockland Utilities, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Terumo Cardiovascular Systems Corporation:医療機器:M&Aディール及び事業提携情報
    Summary Terumo Cardiovascular Systems Corporation (TCSC), a subsidiary of Terumo Corporation, is a provider of medical equipment and devices for cardiac and vascular surgeries. It produces hardware products including heart-lung machines and intra-operative monitoring systems for cardiac surgeries. I …
  • Grand Hotel Varna Resort & Spa:企業の戦略・SWOT・財務情報
    Grand Hotel Varna Resort & Spa - Strategy, SWOT and Corporate Finance Report Summary Grand Hotel Varna Resort & Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Rex International Holding Ltd (5WH):石油・ガス:M&Aディール及び事業提携情報
    Summary Rex International Holding Ltd (Rex International), formerly Rex International Holding Pte Ltd is an independent exploration and production oil company. The company develops oil and gas properties across Singapore. It operates substantial oil and gas exploration concessions in the UAE, Oman, …
  • The Kraft Heinz Co:戦略・SWOT・企業財務分析
    The Kraft Heinz Co - Strategy, SWOT and Corporate Finance Report Summary The Kraft Heinz Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Indiana Resources Limited:企業の戦略・SWOT・財務分析
    Indiana Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Indiana Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Poxel SA (POXEL):企業の財務・戦略的SWOT分析
    Summary Poxel SA (Poxel) is a biopharmaceutical company that focuses to develop drugs for metabolic diseases. The company’s pipeline product portfolio includes Imeglimin, which is developed to target mitochondrial dysfunction, for the treatment of type 2 diabetes; PXL065, a mitochondrial pyruvate ca …
  • Chuo Kagaku Co., Ltd.:企業の戦略・SWOT・財務情報
    Chuo Kagaku Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Chuo Kagaku Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Greggs Plc:企業の戦略・SWOT・財務情報
    Greggs Plc - Strategy, SWOT and Corporate Finance Report Summary Greggs Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Deluxe Corporation
    Deluxe Corporation - Strategy, SWOT and Corporate Finance Report Summary Deluxe Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Damas International Ltd:企業の戦略・SWOT・財務分析
    Damas International Ltd - Strategy, SWOT and Corporate Finance Report Summary Damas International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Devoteam Sa:企業の戦略・SWOT・財務分析
    Devoteam Sa - Strategy, SWOT and Corporate Finance Report Summary Devoteam Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • AU Optronics Corp.:企業の戦略・SWOT・財務情報
    AU Optronics Corp. - Strategy, SWOT and Corporate Finance Report Summary AU Optronics Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • China Petrochemical Development Corporation (1314):企業の財務・戦略的SWOT分析
    China Petrochemical Development Corporation (1314) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Summit Pharmaceuticals International Corp:企業の戦略的SWOT分析
    Summit Pharmaceuticals International Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Enzo Clinical Labs Inc-医療機器分野:企業M&A・提携分析
    Summary Enzo Clinical Labs Inc (Enzo Clinical), a subsidiary of Enzo Biochem Inc is a medical laboratory that offers testing services. The laboratory develops technologies in the areas of gene regulation and gene modification, biomedical and pharmaceutical research markets. It offers physicians seve …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆